Clinical Trial Update: Nafamostat Efficacy and Safety in Critically Ill Patients(NICE) [Phase 3]

View source ↗

Summary

This clinical trial update discusses the efficacy and safety of nafamostat in critically ill patients with acute kidney injury in a Phase 3 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Nafamostat Mesylate (nafamostat)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Acute Kidney Injury | Phase 3 | Status: UNKNOWN